Speech Perception Assessment and Training System
语音感知评估和训练系统
基本信息
- 批准号:6933696
- 负责人:
- 金额:$ 40.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-08-15 至 2007-04-30
- 项目状态:已结题
- 来源:
- 关键词:clinical researchclinical trial phase Icochlear implantscomputer assisted instructioncomputer assisted patient carecomputer system design /evaluationdeaf aiddeafnesseducational resource design /developmenthearing testshuman subjecthuman therapy evaluationpatient oriented researchphonologyspeech recognition
项目摘要
DESCRIPTION (provided by applicant): The goal is a software Speech Perception Assessment and Training System (SPATS) for the aural rehabilitation of adult hearing aid and cochlear-implant users. The system will assess the user's ability to identify the constituents of English syllables; that is, syllable onsets, nuclei, and codas in quiet and in background noise, and it will provide individualized recognition training to improve these abilities. An administrative component of the system will keep and report records and simplify navigation of the system by clinicians and clients. Three parts of the project are: 1) the development of the assessment components of the system, 2) the development of the training components of the system, and 3) their clinical validation.
Assessments will provide an inventory of a client's abilities to identify the constituents of English syllables. Including variation in talkers, phonetic contexts, and noise levels assures that the assessments are valid and objective evaluations of a listener's bottom-up, or analytic, speech-perception abilities. The training algorithm adaptively selects items and noise levels so that practice is concentrated on items of moderate difficulty weighted by their importance for speech understanding. Item importance is estimated from frequency of occurrence data. Further, learning is enhanced by providing many practice trials, immediate feedback, and, following errors, rapid comparisons of intended sounds with their confusors and by including both relatively easy, low-uncertainty and more difficult, high-uncertainty conditions. To better motivate the user and to encourage transfer to real-world speech, briefer periods of training on words and phrases will be regularly interspersed with the training on syllable constituents. Validation studies will measure how well the assessment system predicts success in identifying words and sentences, and general success in speech communication. Correlations with subjective estimates of benefit from, satisfaction with, and use of hearing aids and cochlear implants in relation to the proposed assessment tools will also be measured. Assessment components of the system will be suitable for patient evaluation and for the evaluation of the performance of hearing-aids and their fittings as well as for the evaluation of the performance of cochlear implants, maps, programs, and processing schemes. The effectiveness of the training system for improving the validation measures and, thus, the clients' overall ability to understand speech, will be measured. The training components of the system can be used in aural rehabilitation programs in clinical settings and in the home.
描述(由申请人提供):目标是一个用于成人助听器和人工耳蜗用户听力康复的软件言语感知评估和训练系统(SPATS)。该系统将评估用户的能力,以确定英语音节的成分,即,音节起始,核,尾在安静和背景噪音,它将提供个性化的识别训练,以提高这些能力。该系统的一个管理组件将保存和报告记录,并简化临床医生和客户对系统的导航。该项目的三个部分是:1)系统评估组件的开发,2)系统培训组件的开发,以及3)其临床验证。
评估将提供一个清单的客户的能力,以确定英语音节的组成部分。包括谈话者,语音环境和噪音水平的变化,确保评估是有效的和客观的评价听者的自下而上,或分析,语音感知能力。训练算法自适应地选择项目和噪声水平,使实践集中在中等难度的项目加权的重要性,为语音理解。项目的重要性是从发生频率数据估计。此外,通过提供许多实践试验,即时反馈,以及在错误之后,将预期声音与其混淆器进行快速比较,以及通过包括相对容易的、低不确定性和更困难的、高不确定性的条件来增强学习。为了更好地激励用户并鼓励转移到真实世界的语音中,单词和短语的简短训练将定期与音节成分的训练穿插在一起。验证研究将衡量评估系统在识别单词和句子方面的预测成功率,以及语音交流的总体成功率。还将测量与拟议评估工具相关的助听器和人工耳蜗植入物的受益、满意度和使用的主观估计的相关性。该系统的评估组件将适用于患者评估和助听器及其配件的性能评估,以及人工耳蜗植入物、地图、程序和处理方案的性能评估。将衡量培训系统对改进验证措施的有效性,从而衡量客户理解语言的总体能力。该系统的训练组件可用于临床环境和家庭中的听觉康复计划。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
James D Miller其他文献
Sharing clinical research data in the United States under the health insurance portability and accountability act and the privacy rule
- DOI:
10.1186/1745-6215-11-112 - 发表时间:
2010-11-19 - 期刊:
- 影响因子:2.000
- 作者:
James D Miller - 通讯作者:
James D Miller
James D Miller的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('James D Miller', 18)}}的其他基金
Speech Perception Assessment and Training System for Aphasia Rehabilitation
失语康复言语感知评估与训练系统
- 批准号:
8001891 - 财政年份:2010
- 资助金额:
$ 40.37万 - 项目类别:
Learn to Listen: Second Langauage Speech Perception Traininng System for English
学会听:英语第二语言言语感知训练系统
- 批准号:
7327050 - 财政年份:2007
- 资助金额:
$ 40.37万 - 项目类别:
相似海外基金
CLINICAL TRIAL: PHASE I EVALUATION OF A LIVE ATTENUATED DEN4 VACCINE
临床试验:DEN4 减毒活疫苗的 I 期评估
- 批准号:
8166998 - 财政年份:2010
- 资助金额:
$ 40.37万 - 项目类别:
CLINICAL TRIAL: PHASE I/II TRIAL USING CYCLOPHOSPHAMIDE AND LOW-DOSE IL-2 TO IN
临床试验:使用环磷酰胺和低剂量 IL-2 进行 I/II 期试验
- 批准号:
8356778 - 财政年份:2010
- 资助金额:
$ 40.37万 - 项目类别:
CLINICAL TRIAL: PHASE I/II TRIAL USING CYCLOPHOSPHAMIDE AND LOW-DOSE IL-2 TO IND
临床试验:使用环磷酰胺和低剂量 IL-2 进行 IND 的 I/II 期试验
- 批准号:
8166775 - 财政年份:2009
- 资助金额:
$ 40.37万 - 项目类别:
CLINICAL TRIAL: PHASE I STUDY OF INTRANASAL NORWALK VLP VACCINE WITH ADJUVANT &
临床试验:鼻内 NORWALK VLP 疫苗与佐剂的 I 期研究
- 批准号:
7951170 - 财政年份:2009
- 资助金额:
$ 40.37万 - 项目类别:
CLINICAL TRIAL: PHASE I AND PHARMACOKINETIC STUDY OF ENZASTAURIN (LY317615) IN C
临床试验:ENZASTAURIN (LY317615) 在 C 中的 I 期和药代动力学研究
- 批准号:
8166706 - 财政年份:2009
- 资助金额:
$ 40.37万 - 项目类别:
CLINICAL TRIAL: PHASE I DOSE ESCALATION STUDY OF AUTOLOGOUS TUMOR LYSATE-PULSED
临床试验:自体肿瘤裂解物脉冲的 I 期剂量递增研究
- 批准号:
7951529 - 财政年份:2009
- 资助金额:
$ 40.37万 - 项目类别:
CLINICAL TRIAL: PHASE I/II STUDY OF A BOOSTER DOSE OF A/H5N1/INDONESIA/05/05 (CL
临床试验:A/H5N1 加强剂量的 I/II 期研究/INDONESIA/05/05 (CL
- 批准号:
7951184 - 财政年份:2009
- 资助金额:
$ 40.37万 - 项目类别:
CLINICAL TRIAL: PHASE I DOSE ESCALATION STUDY OF AUTOLOGOUS TUMOR LYSATE-PULSED
临床试验:自体肿瘤裂解物脉冲的 I 期剂量递增研究
- 批准号:
8167071 - 财政年份:2009
- 资助金额:
$ 40.37万 - 项目类别:
CLINICAL TRIAL: PHASE I PRIME-BOOST STUDY OF VI POLYSACCHARIDE TYPHOID VACCINE A
临床试验:VI多糖伤寒疫苗A的I期初免-加强研究
- 批准号:
7951156 - 财政年份:2009
- 资助金额:
$ 40.37万 - 项目类别:
CLINICAL TRIAL: PHASE I TRIAL OF VORINOSTAT (SAHA) IN COMBINATION WITH FLAVOPIRI
临床试验:伏立诺他 (SAHA) 与 FLAVOPIRI 联用的 I 期试验
- 批准号:
8166543 - 财政年份:2009
- 资助金额:
$ 40.37万 - 项目类别: